PTHS
Pelthos Therapeutics Inc. Common Stock (PTHS)
$60
About Pelthos Therapeutics Inc. Common Stock (PTHS)
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Details
Daily high
$21.18
Daily low
$20.11
Price at open
$20.11
52 Week High
$37.50
52 Week Low
$18.19
Market cap
77.9M
Dividend yield
-
Volume
22,028
Avg. volume
32,200
P/E ratio
-.77
Pelthos Therapeutics Inc. Common Stock News
Details
Daily high
$21.18
Daily low
$20.11
Price at open
$20.11
52 Week High
$37.50
52 Week Low
$18.19
Market cap
77.9M
Dividend yield
-
Volume
22,028
Avg. volume
32,200
P/E ratio
-.77